Charles Cooper
Chief Tech/Sci/R&D Officer at BIOMÉRIEUX
Profile
Charles K Cooper is currently the Chief Medical Officer & Executive Vice President at bioMérieux SA since 2024.
Prior to this, he worked as the Chief Medical Officer at Siemens Healthcare GmbH.
He completed his undergraduate degree from Georgetown University School of Medicine.
Charles Cooper active positions
| Companies | Position | Start |
|---|---|---|
| BIOMÉRIEUX | Chief Tech/Sci/R&D Officer | 01/01/2024 |
Former positions of Charles Cooper
| Companies | Position | End |
|---|---|---|
Siemens Healthcare GmbH
 Siemens Healthcare GmbH Medical DistributorsDistribution Services Siemens Healthcare GmbH provides healthcare services. Its products and services include medical imaging, ultrasound, laboratory diagnostics, point-of-care testing, healthcare, clinical specialties & diseases. It operates through following business segments: Imaging, Diagnostics and Advanced Therapies. The Imaging segment offers diagnostic imaging products and a broad portfolio of advanced imaging and ultrasound systems and solutions. The Diagnostics segment offers products, services and solutions, including a broad array of testing applications, in the areas of laboratory, point of care and molecular diagnostics. The Advanced Therapies segment is a supplier of advanced therapy products, services and solutions to the therapy departments of healthcare providers. The company was founded on May 1, 2015 and is headquartered in Erlangen, Germany. | Chief Tech/Sci/R&D Officer | - |
Training of Charles Cooper
| Georgetown University School of Medicine | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BIOMÉRIEUX | Health Technology |
| Private companies | 1 |
|---|---|
Siemens Healthcare GmbH
Siemens Healthcare GmbH Medical DistributorsDistribution Services Siemens Healthcare GmbH provides healthcare services. Its products and services include medical imaging, ultrasound, laboratory diagnostics, point-of-care testing, healthcare, clinical specialties & diseases. It operates through following business segments: Imaging, Diagnostics and Advanced Therapies. The Imaging segment offers diagnostic imaging products and a broad portfolio of advanced imaging and ultrasound systems and solutions. The Diagnostics segment offers products, services and solutions, including a broad array of testing applications, in the areas of laboratory, point of care and molecular diagnostics. The Advanced Therapies segment is a supplier of advanced therapy products, services and solutions to the therapy departments of healthcare providers. The company was founded on May 1, 2015 and is headquartered in Erlangen, Germany. | Distribution Services |
- Stock Market
- Insiders
- Charles Cooper
